OrganizationLOUISIANA
United States Food and Drug Administration
- Records
- 4
- Related bills
- 4
- Finance entries
- 0
- Connections
- 0
Save this entity to revisit their record, finance activity, and connections.
What This Entity Does
The available records identify this entity, but do not yet include a plain-English role description.
Recent Record
4 records name this entity, but none of them carry a date yet, so there is nothing to place on a timeline.
Browse the local feed →Related Bills
CONTROLLED SUBSTANCES: Provides with respect to the possession of Kratom (OR SEE FISC NOTE GF EX)“Federal agency referenced regarding pharmaceutical product approvals and food solvents”INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)INSURANCE/HEALTH: Provides relative to expand glucose-improving medications coverage to individuals based on body mass index (OR INCREASE EX See Note)FEES/LICENSES/PERMITS: Provides relative to vapor products, alternative nicotine products, and modified risk tobacco products (EN DECREASE GF RV See Note)
Not In The Record Yet
POLISCOPE has no finance activity or mapped connections for this entity in the records it has processed. That is a gap in coverage, not a finding about the entity.
Source Trail
Documents where this entity appears. Each item opens the Bill Dossier, which includes the official source URL when available.
- May 19, 2026State BillCONTROLLED SUBSTANCES: Provides with respect to the possession of Kratom (OR SEE FISC NOTE GF EX)
- Jun 12, 2026State BillINSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)
- Mar 9, 2026State BillINSURANCE/HEALTH: Provides relative to expand glucose-improving medications coverage to individuals based on body mass index (OR INCREASE EX See Note)
- Jun 23, 2026State BillFEES/LICENSES/PERMITS: Provides relative to vapor products, alternative nicotine products, and modified risk tobacco products (EN DECREASE GF RV See Note)